Inovio Pharmaceuticals is trading at $0.92, up 5.48%; available search results identify no company-specific announcement dated October 27 explaining the gain. - Latest company news was an October 20 court judgment for $80,416,101; the company warned defendants’ financial condition may limit collection. - The FDA target action date for INO-3107 is October 30, but available sources do not establish that this or broader market conditions caused the October 27 gain.